Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > SAVA Cassava Sciences > Detailed Quotes

SAVA Cassava Sciences

41.820
-1.250-2.90%
Close 09/30 16:00 ET
42.000
+0.180+0.43%
Post Mkt Price 09/30 19:15 ET
High
44.800
Open
42.630
Turnover
87.07M
Low
41.080
Pre Close
43.070
Volume
2.04M
Market Cap
1.68B
P/E(TTM)
Loss
52wk High
100.000
Shares
40.10M
P/E(Static)
Loss
52wk Low
13.840
Float Cap
1.53B
Bid/Ask %
-86.67%
Historical High
146.160
Shs Float
36.51M
Volume Ratio
0.30
Historical Low
1.000
Dividend TTM
--
Div Yield TTM
--
P/B
7.68
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
5.59%
Amplitude
8.64%
Avg Price
42.693
Lot Size
1
Float Cap
1.53B
Bid/Ask %
-86.67%
Historical High
146.160
Shs Float
36.51M
Volume Ratio
0.30
Historical Low
1.000
Dividend TTM
--
P/B
7.68
Dividend LFY
--
Turnover Ratio
5.59%
Amplitude
8.64%
Avg Price
42.693
Lot Size
1
Price Forecast

No Data

News

Comment

No More
Company Overview More
Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier and Barry M. Sherman in May 1998 and is headquartered in Austin, TX.
CEO: Mr. Remi Barbier
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...